M. Soulié

发表

[Place of contrast imaging in prostate cancer detection].

A. Villers, M. Peyromaure, X. Rébillard, 2006, Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie.

Prostate cancer incidence on cystoprostatectomy specimens is directly linked to age: results from a multicentre study

L. Salomon, G. Pignot, N. Houédé, 2015, BJU international.

Migration of an abdominal mesh into a reconstructed ileal neobladder, diagnosis and management: A case report

É. Huyghe, M. Soulié, J. Zgheib, 2019, Urology case reports.

Techniques of Ureteral Imaging

M. Millán, F. Joffre, P. Otal, 2003 .

[Screening of cancer of the prostate (IV). Economic approach: the costs of screening tests and treatment. Members of the Sub-Committee of the Prostate of CCAFU].

A. Villers, M. Soulié, O. Haillot, 1998, Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie.

High‐intensity focused ultrasound in prostate cancer; a systematic literature review of the French Association of Urology

X. Rébillard, E. Chartier-Kastler, M. Soulié, 2008, BJU international.

[Functional results and treatment of functional dysfunctions after radical prostatectomy].

L. Salomon, R. Yiou, M. Soulié, 2015, Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie.

[What is the clinical practice of partial nephrectomy in France?].

F. Guillé, J. Patard, A. Ravaud, 2008, Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie.

[Do broader indications for partial nephrectomy result in excess morbidity?].

K. Bensalah, F. Guillé, J. Patard, 2008, Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie.

Quelle pratique de la néphrectomie partielle en France

F. Guillé, J. Patard, A. Ravaud, 2008 .

Morbidity and clinical outcome of nephron-sparing surgery in relation to tumour size and indication.

F. Guillé, J. Patard, J. Bernhard, 2006, European urology.

[Recommendations Onco-Urology 2010: Prostate cancer].

L. Salomon, A. Villers, M. Peyromaure, 2010, Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie.

[The role and method of fluorescence-guided cystoscopy in 2011 for management of bladder cancer: Review of the Oncology Committee of the French Urology Association].

H. Wallerand, G. Pignot, N. Houédé, 2011, Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie.

[Oncological outcomes of prostate cancer surgery].

L. Salomon, M. Soulié, M. Soulie, 2015, Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie.

Robot-assisted post-chemotherapy retroperitoneal lymph node dissection in germ cell tumor: is the single-docking with lateral approach relevant?

N. Doumerc, P. Rischmann, M. Soulié, 2018, World Journal of Urology.

Radiological Imaging of the Ureter

F. Joffre, P. Otal, M. Soulié, 2003, Medical Radiology.

[Medical castration in the treatment of locally advanced or metastatic prostate cancer: an update].

M. Rouprêt, M. Soulié, S. Drouin, 2009, Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie.

[CCAFU Recommendations 2013: Penile cancer].

S. Culine, P. Camparo, P. Sèbe, 2013, Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie.

[Clamping modalities during partial nephrectomy: technical aspects and functional consequences. Review by the Comité de cancérologie de l'Association française d'urologie (CCAFU)].

N. Rioux-Leclercq, J. Patard, L. Salomon, 2009, Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie.

Retroperitoneal laparoscopic versus open pyeloplasty with a minimal incision: comparison of two surgical approaches.

M. Thoulouzan, P. Plante, M. Soulié, 2001, Urology.

[Intradiverticular bladder tumours: review of the Cancer Committee of the French Association of Urology].

H. Wallerand, G. Pignot, N. Houédé, 2012, Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie.

Intercenter reproducibility of software-based fusion biopsies for grade group prediction when targeting suspicious MRI lesions.

C. Almeras, O. Meyrignac, B. Malavaud, 2020, Urologic oncology.

Improvement of the intermediate risk prostate cancer sub-classification by integrating MRI and fusion biopsy features.

C. Almeras, N. Doumerc, B. Malavaud, 2020, Urologic oncology.

Confirmation by Early Oncologic Outcomes After Surgery of the Accuracy of Intermediate-risk Prostate Cancer Classification Based on Magnetic Resonance Imaging Staging and Targeted Biopsy

C. Almeras, B. Malavaud, M. Soulié, 2020, European urology open science.

Assessment of the Minimal Targeted Biopsy Core Number per MRI Lesion for Improving Prostate Cancer Grading Prediction

C. Almeras, D. Portalez, B. Malavaud, 2020, Journal of clinical medicine.

Added Value of Concomitant Systematic and Fusion Targeted Biopsies for Grade Group Prediction Based on Radical Prostatectomy Final Pathology on Positive Magnetic Resonance Imaging

C. Almeras, D. Portalez, B. Malavaud, 2019 .

Decreased accuracy of the prostate cancer EAU risk group classification in the era of imaging-guided diagnostic pathway: proposal for a new classification based on MRI-targeted biopsies and early oncologic outcomes after surgery

C. Almeras, B. Malavaud, M. Soulié, 2019, World Journal of Urology.

Contamination in control group led to no effect of PSA-based screening on prostate cancer mortality at 9 years follow-up: Results of the French section of European Randomized Study of Screening for Prostate Cancer (ERSPC).

A. Villers, E. Heijnsdijk, J. Hugosson, 2020, Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie.

The use of partial nephrectomy: results from a contemporary national prospective multicenter study

K. Bensalah, J. Patard, J. Bernhard, 2014, World Journal of Urology.

Clinicopathological Characteristics of Incidental Prostate Cancer Discovered from Radical Cystoprostatectomy Specimen: A Multicenter French Study

A. Masson-Lecomte, J. Patard, J. Bernhard, 2014, Annals of Surgical Oncology.

Anticancer Activity and Tolerance of Treatments Received Beyond Progression in Men Treated Upfront with Androgen Deprivation Therapy With or Without Docetaxel for Metastatic Castration-naïve Prostate Cancer in the GETUG-AFU 15 Phase 3 Trial.

A. Ravaud, S. Culine, J. Machiels, 2017, European urology.

Prognostic factors after adrenalectomy for adrenal metastasis

K. Bensalah, F. Saint, F. Bruyère, 2020, International Urology and Nephrology.

Indications de la lymphadénectomie ilio-obturatrice dans le cancer de la prostate cliniquement localisé

A. Villers, V. Molinie, M. Soulié, 2004 .

Impact of a modified apical dissection during radical retropubic prostatectomy on the occurrence of positive surgical margins: a comparative study in 212 patients.

P. Plante, M. Soulié, G. Escourrou, 2001, Urology.

Androgen Deprivation Therapy (ADT) Plus Docetaxel Versus ADT Alone in Metastatic Non castrate Prostate Cancer: Impact of Metastatic Burden and Long-term Survival Analysis of the Randomized Phase 3 GETUG-AFU15 Trial.

S. Culine, G. Deplanque, S. Oudard, 2016, European urology.

Laparoscopy for living donor left nephrectomy: Comparison of three‐dimensional and two‐dimensional vision

X. Gamé, N. Doumerc, N. Kamar, 2019, Clinical transplantation.

The Cumulated Stone Diameter: A Limited Tool for Stone Burden Estimation.

I. Tack, É. Huyghe, P. Rischmann, 2015, Urology.

External Validation of a Predictive Model to Estimate Renal Function After Living Donor Nephrectomy

X. Gamé, N. Kamar, C. Legendre, 2021, Transplantation.

Nephron-sparing surgery is superior to radical nephrectomy in preserving renal function benefit even when expanding indications beyond the traditional 4-cm cutoff.

K. Bensalah, J. Patard, J. Bernhard, 2014, Urologic oncology.

Are warm ischemia and ischemia time still predictive factors of poor renal function after partial nephrectomy in the setting of elective indication?

K. Bensalah, J. Patard, J. Bernhard, 2014, World Journal of Urology.

Metachronous bilateral renal cell carcinoma: risk assessment, prognosis and relevance of the primary-free interval.

J. Patard, J. Bernhard, J. Lam, 2007, The Journal of urology.

[Use of local estrogenotherapy in urology and pelviperineology: A systematic review].

X. Gamé, J. Arnal, P. Gourdy, 2015, Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie.

[Active surveillance for localized prostate cancer].

L. Salomon, M. Peyromaure, N. Mottet, 2011, Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie.

MRI evaluation following partial HIFU therapy for localized prostate cancer: A single-center study.

X. Gamé, D. Portalez, B. Malavaud, 2016, Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie.

Performance of systematic, MRI-targeted biopsies alone or in combination for the prediction of unfavourable disease in MRI-positive low-risk prostate cancer patients eligible for active surveillance

C. Almeras, D. Portalez, B. Malavaud, 2019, World Journal of Urology.

Active surveillance eligibility of MRI-positive patients with grade group 2 prostate cancer: a pathological study

C. Almeras, D. Portalez, B. Malavaud, 2019, World Journal of Urology.

Impact of MRI and targeted biopsies on eligibility and disease reclassification in MRI-positive candidates for active surveillance on systematic biopsies.

C. Almeras, D. Portalez, B. Malavaud, 2019, Urology.

[Recommendations for the treatment of prostate cancer in the elderly man: A study by the oncology committee of the French association of urology].

L. Salomon, M. Peyromaure, J. Droz, 2009, Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie.

[Progress in prostate cancer study: 3D cell culture enables the ex vivo reproduction of tumor characteristics].

X. Gamé, C. Racaud-Sultan, M. Soulié, 2017, Presse medicale.

[Mechanisms of castration resistance: Intratumoral hypoxia stimulates the androgen receptor expression].

O. Cuvillier, B. Malavaud, M. Soulié, 2016, Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie.

[CCAFU's contribution to the French National Cancer Institute's reference frame: Adrenal malignant tumors].

P. Camparo, P. Sèbe, L. Brunaud, 2013, Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie.

Who is dying after nephrectomy for cancer? Study of risk factors and causes of death after analyzing morbidity and mortality reviews (UroCCR-33 study).

K. Bensalah, J. Bernhard, L. Salomon, 2019, Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie.

Biochemical recurrence-free survival and pathological outcomes after radical prostatectomy for high-risk prostate cancer

L. Salomon, A. De la taille, B. Malavaud, 2016, BMC Urology.

[Severe (RTOG grades 3 or 4) long-term complications of adjuvant radiotherapy after total prostatectomy].

J. Bachaud, É. Huyghe, P. Plante, 2006, Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie.

Management of Node Only Recurrence after Primary Local Treatment for Prostate Cancer: A Systematic Review of the Literature.

V. Flamand, A. Villers, A. Briganti, 2015, The Journal of urology.

Effect of nonsteroidal anti-inflammatory agents and finasteride on prostate cancer risk.

F. Bladou, V. Ravery, E. Chartier-Kastler, 2002, The Journal of urology.

Projection de l’incidence et de la mortalité par cancer urologique en France en 2012

J. Patard, L. Salomon, A. Villers, 2013 .

Projection de l’incidence et de la mortalité par cancer urologique en France en 2010

J. Patard, L. Salomon, X. Rébillard, 2010 .

A proportion of hereditary upper urinary tract urothelial carcinomas are misclassified as sporadic according to a multi‐institutional database analysis: proposal of patient‐specific risk identification tool

F. Saint, A. Ouzzane, O. Cussenot, 2012, BJU international.

A population-based study on radical prostatectomy in France

A. Villers, J. Macé-Lesec’h, P. Grosclaude, 2001, Prostate Cancer and Prostatic Diseases.

[Prostate cancer screening (III): risk factors, natural history, course without treatment. Characteristics of detected cancers].

M. Soulié, O. Haillot, L. Boccon‐Gibod, 1997, Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie.

Overall survival and oncological outcomes after partial nephrectomy and radical nephrectomy for cT2a renal tumors: A collaborative international study from the French kidney cancer research network UroCCR.

K. Bensalah, J. Patard, J. Bernhard, 2018, Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie.

Prognostic variables to predict cancer‐related death in incidental renal tumours

K. Bensalah, F. Guillé, J. Patard, 2008, BJU international.

[5 alpha-reductase inhibitors and prostate cancer: a statement of the Committee of Cancerology of the French Association of Urology].

L. Salomon, M. Peyromaure, C. Hennequin, 2012, Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie.

[First line indications for hormonal therapy in prostate cancer].

S. Culine, M. Zerbib, P. Richaud, 2010, Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie.

[Competitive morbidity ant its impact on life expectancy: evaluation and inclusion in the therapeutic decision regarding localized prostatic cancer].

A. Villers, P. Grosclaude, A. Ruffion, 2001, Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie.

[The role and principles of radiotherapy in prostate cancer in the elderly subject].

L. Salomon, M. Peyromaure, V. Molinie, 2009, Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie.

Renal cell carcinoma (RCC) in patients with end-stage renal disease exhibits many favourable clinical, pathologic, and outcome features compared with RCC in the general population.

N. Rioux-Leclercq, J. Patard, H. Wallerand, 2011, European urology.

A population-based study on management of prostate cancer in four regions of France

A. Villers, L. Molinier, J. Macé-Lesec’h, 2001, Prostate Cancer and Prostatic Diseases.

Management of urinary-tract fistulas using reversible balloon nephrostomy: a single-center retrospective analysis of 56 patients

X. Gamé, F. Nouhaud, J. Gas, 2019, International Urogynecology Journal.

Radical Cystectomy in Patients Older than 75 Years: Assessment of Morbidity and Mortality

X. Gamé, P. Plante, M. Soulié, 2001, European Urology.

Aspects urologiques de l’infection à Polyomavirus

N. Kamar, M. Thoulouzan, É. Huyghe, 2010 .

The subclassification of papillary renal cell carcinoma does not affect oncological outcomes after nephron sparing surgery

K. Bensalah, J. Patard, J. Bernhard, 2016, World Journal of Urology.

MP63-15 THE SUBCLASSIFICATION OF PAPILLARY RENAL CELL CARCINOMA DOES NOT AFFECT ONCOLOGICAL OUTCOMES AFTER NEPHRON SPARING SURGERY.

K. Bensalah, J. Patard, J. Bernhard, 2015 .

[CCAFU Recommendations 2013: Testicular germ cell cancer].

S. Culine, P. Camparo, P. Sèbe, 2013, Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie.

Prognostic Factors for Survival in Noncastrate Metastatic Prostate Cancer: Validation of the Glass Model and Development of a Novel Simplified Prognostic Model.

A. Ravaud, J. Machiels, G. Deplanque, 2015, European urology.

Initial management of testicular cancer: practice survey among urologists and pathologists.

S. Culine, P. Camparo, P. Sèbe, 2014, Clinical genitourinary cancer.

Conservative management of small testicular tumors relative to carcinoma in situ prevalence.

É. Huyghe, R. Mieusset, P. Plante, 2005, The Journal of urology.

[CCAFU Recommendations 2013: Bladder carcinoma].

E. Compérat, P. Colin, G. Pignot, 2013, Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie.

[Benefit of bladder and upper urinary tract urothelial tumors lymph node dissection: review from the Bladder Cancer Committee of the French National Association of Urology ("CC-AFU Vessie")].

H. Wallerand, H. Quintens, G. Pignot, 2012, Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie.

[Chemotherapy in perioperative setting for infiltrative bladder cancer].

S. Culine, N. Houédé, P. Beuzeboc, 2012, Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie.

Dose-Dense Methotrexate, Vinblastine, Doxorubicin, and Cisplatin or Gemcitabine and Cisplatin as Perioperative Chemotherapy for Patients With Nonmetastatic Muscle-Invasive Bladder Cancer: Results of the GETUG-AFU V05 VESPER Trial

S. Culine, Y. Allory, G. Gravis, 2022, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Randomized Phase III Trial of Dose-dense Methotrexate, Vinblastine, Doxorubicin, and Cisplatin, or Gemcitabine and Cisplatin as Perioperative Chemotherapy for Patients with Muscle-invasive Bladder Cancer. Analysis of the GETUG/AFU V05 VESPER Trial Secondary Endpoints: Chemotherapy Toxicity and Patho

S. Culine, Y. Allory, G. Gravis, 2020, European urology.

Intra-database validation of case-identifying algorithms using reconstituted electronic from data

C. Louapre, E. Bignon, R. Lassalle, 2021 .

Laparoscopic pelvic exenteration for gynaecological malignancy: is there any advantage?

C. Pomel, D. Querleu, T. Filleron, 2011, Gynecologic oncology.

[Surgical treatment of metastatic urothelial carcinoma of the bladder: Review of the Cancer Committee of the French Association of Urology].

H. Wallerand, G. Pignot, N. Houédé, 2013, Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie.

Post‐chemotherapy retroperitoneal teratoma in nonseminomatous germ cell tumors: Do predictive factors exist? Results from a national multicenter study

L. Salomon, P. Sèbe, G. Pignot, 2016, Journal of surgical oncology.

Long-term efficacy of two cycles of BEP regimen in high-risk stage I nonseminomatous testicular germ cell tumors with embryonal carcinoma and/or vascular invasion.

J. Bachaud, B. Malavaud, L. Bujan, 2004, European urology.

Synchronous Epidermoid Cyst and Mature Teratoma of the Testis: An Unusual Association

C. Moran, É. Huyghe, P. Plante, 2007, Urologia Internationalis.

[Progress and summary of recent congress: ASCO-GU, EAU, AUA, ASCO about the medical management of locally advanced or metastatic kidney cancer].

N. Rioux-Leclercq, J. Patard, H. Lang, 2010, Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie.

Influence of previous or synchronous bladder cancer on oncologic outcomes after radical nephroureterectomy for upper urinary tract urothelial carcinoma.

S. Crouzet, P. Colin, J. Long, 2014, Urologic oncology.

Abiraterone acetate versus docetaxel for metastatic castration-resistant prostate cancer: a cohort study within the French nationwide claims database

G. de Pouvourville, N. Moore, X. Rébillard, 2022, Expert review of clinical pharmacology.

Predictive factors of oncologic outcomes in patients who do not achieve undetectable prostate specific antigen after radical prostatectomy.

L. Salomon, A. Villers, M. Rouprêt, 2013, The Journal of urology.

Patient selection for laparoscopic excision of adrenal metastases: A multicenter cohort study.

K. Bensalah, N. Rioux-Leclercq, P. Caron, 2015, International journal of surgery.

Quality of life and functional outcomes after radical cystectomy with ileal orthotopic neobladder replacement for bladder cancer: a multicentre observational study

X. Gamé, J. Gas, P. Coloby, 2020, World Journal of Urology.

[Prostate cancer 2010. Therapeutic innovations].

S. Culine, L. Salomon, C. Hennequin, 2011, Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique.

Oncologic Outcomes and Survival in pT0 Tumors After Radical Cystectomy in Patients Without Neoadjuvant Chemotherapy: Results from a Large Multicentre Collaborative Study

K. Bensalah, J. Patard, H. Wallerand, 2011, Annals of Surgical Oncology.

Postoperative and Posttransplantation Ureter

B. J. d’Othée, F. Joffre, M. Soulié, 2003 .

Conventional versus automated implantation of loose seeds in prostate brachytherapy: analysis of dosimetric and clinical results.

T. Brun, J. Bachaud, M. Thoulouzan, 2013, International journal of radiation oncology, biology, physics.

Pubourethral ligaments in women: anatomical and clinical aspects

J. Bécue, P. Plante, M. Soulié, 2002, Surgical and Radiologic Anatomy.

Epidemiology of metastatic castration-resistant prostate cancer: A first estimate of incidence and prevalence using the French nationwide healthcare database.

N. Moore, E. Bignon, X. Rébillard, 2020, Cancer epidemiology.

Assessment of oncological and functional outcomes of retropubic radical prostatectomy: An academic center experience.

X. Gamé, N. Doumerc, M. Soulié, 2021, Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie.

Pathological and Surgical Outcomes of Retropubic Radical Prostatectomy in an Academic Center: A Contemporary Study

X. Gamé, N. Doumerc, M. Thoulouzan, 2021, Archives of Clinical and Biomedical Research.

Comparison between retroperitoneal and transperitoneal laparoscopic adrenalectomy: Are both equally safe?

J. Gas, M. Thoulouzan, É. Huyghe, 2020, Journal of visceral surgery.

Effectiveness of Early Radical Cystectomy for High-Risk Non-Muscle Invasive Bladder Cancer

A. De la taille, M. Rouprêt, D. Vordos, 2022, Cancers.

[Radical cystectomy for urothelial bladder cancer: prognostic impact of lymph node metastasis and soft tissue surgical margins].

M. Thoulouzan, C. Bastide, E. Ragni, 2012, Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie.

Efficacy and tolerance of one‐third full dose bacillus Calmette–Guérin maintenance therapy every 3 months or 6 months: Two‐year results of URO‐BCG‐4 multicenter study

H. Wallerand, F. Saint, M. Colombel, 2015, International journal of urology : official journal of the Japanese Urological Association.

[Treatment of small renal masses: Effectiveness and cost-comparison analysis].

X. Gamé, B. Malavaud, P. Rischmann, 2016, Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie.

Prognostic interest in discriminating muscularis mucosa invasion (T1a vs T1b) in nonmuscle invasive bladder carcinoma: French national multicenter study with central pathology review.

P. Validire, E. Compérat, M. Rouprêt, 2013, The Journal of urology.

Are gastric metastases of renal cell carcinoma really rare? A case report and systematic review of the literature

F. Mokrane, F. Muscari, M. Soulié, 2021, International journal of surgery case reports.

Positive surgical margins and their locations in specimens are adverse prognosis features after radical cystectomy in non‐metastatic carcinoma invading bladder muscle: results from a nationwide case–control study

J. Patard, L. Salomon, A. Valéri, 2013, BJU international.

Impact of preoperative 5-alpha reductase inhibitor treatment in holmium laser enucleation of the prostate

X. Gamé, M. Soulié, M. Roumiguié, 2022, Progrès en Urologie.

Burden of metastatic hormone-sensitive prostate cancer to identify men more likely to benefit from early docetaxel.

R. DiPaola, M. Carducci, M. Kohli, 2017 .

[Management of pure teratoma of the testis in adult, results of a multicenter study over 15 years].

M. Thoulouzan, É. Huyghe, C. Chevreau, 2008, Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie.

Final results of the phase III URO-BCG 4 multicenter study: efficacy and tolerance of one-third dose BCG maintenance in nonmuscle invasive bladder cancer

F. Saint, M. Colombel, F. Nouhaud, 2017, Anti-cancer drugs.

[Bacillus Calmette-Guerin maintenance treatment in non-invasive bladder tumors: 1 year follow-up results of multicenter URO-BCG-4 trial].

H. Wallerand, F. Saint, M. Colombel, 2013, Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie.

[What's new in 2008 in the field of basic and clinical research in prostate cancer?].

L. Salomon, M. Rouprêt, M. Soulié, 2009, Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie.

What's New in Prostate Cancer: Highlights from Urologic and Oncologic Congresses in 2006

L. Salomon, N. Mottet, J. Irani, 2007 .

Ureteral Lithiasis and Other Intraluminal Diseases

F. Joffre, P. Otal, M. Soulié, 2003 .

Polyorchidism: Presentation of 2 Cases, Review of the Literature and a New Management Strategy

É. Huyghe, P. Plante, P. Thonneau, 2008, Urologia Internationalis.

Definition of lymph node areas for radiotherapy of prostate cancer: A critical literature review by the French Genito-Urinary Group and the French Association of Urology (GETUG-AFU).

S. Guérif, R. de Crevoisier, C. Hennequin, 2015, Cancer treatment reviews.

Burden of Metastatic Castrate Naive Prostate Cancer Patients, to Identify Men More Likely to Benefit from Early Docetaxel: Further Analyses of CHAARTED and GETUG-AFU15 Studies.

R. DiPaola, M. Carducci, M. Kohli, 2018, European urology.

Predictive factors for ipsilateral recurrence after nephron-sparing surgery in renal cell carcinoma.

K. Bensalah, J. Patard, H. Wallerand, 2008, European urology.

[Penile cancer in 2010: update from the Oncology Committee of the French Association of Urology: external genital organs group (CCAFU-OGE)].

C. Haie-meder, S. Culine, P. Camparo, 2011, Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie.

Interventional Radiology of the Ureter

H. Rousseau, T. Smayra, M. Millán, 2003 .

Creation of the Miami Pouch During Laparoscopic-Assisted Pelvic Exenteration: The Initial Experience

C. Pomel, D. Querleu, G. Ferron, 2008, International Journal of Gynecologic Cancer.

Subinguinal microsurgical varicocelectomy vs. percutaneous embolization in infertile men: Prospective comparison of reproductive and functional outcomes

É. Huyghe, P. Rischmann, M. Soulié, 2017, Basic and Clinical Andrology.

[Comparison of subinguinal microsurgical varicocelectomy vs percutaneous embolization in infertile men].

É. Huyghe, M. Soulié, T. Almont, 2016, Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie.

[Prostate cancer screening (II): is prostate cancer a public health problem? Update of incidence and mortality figures in France from 1982 to 1990].

A. Villers, P. Arveux, P. Grosclaude, 1997, Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie.

Intradetrusor injections of onabotulinum toxin A (Botox®) 300 U or 200 U versus abobotulinum toxin A (Dysport®) 750 U in the management of neurogenic detrusor overactivity: A case control study

P. Marque, E. Castel-Lacanal, B. Peyronnet, 2016, Neurourology and urodynamics.

[Oncological principles for local control of primary tumor].

L. Salomon, M. Soulié, G. Portier, 2015, Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie.

[Fusion genes and prostate cancer. From discovery to prognosis and therapeutic perspectives].

L. Salomon, M. Peyromaure, V. Molinie, 2009, Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie.

External validation of the Briganti nomogram to estimate the probability of specimen‐confined disease in patients with high‐risk prostate cancer

L. Salomon, A. Taille, B. Malavaud, 2014, BJU international.

Cancer-specific survival after radical nephroureterectomy for upper urinary tract urothelial carcinoma: proposal and multi-institutional validation of a post-operative nomogram

S. Crouzet, A. Ouzzane, O. Cussenot, 2012, British Journal of Cancer.

Radical prostatectomy for high-risk prostate cancer defined by preoperative criteria: oncologic follow-up in national multicenter study in 813 patients and assessment of easy-to-use prognostic substratification.

A. Masson-Lecomte, L. Salomon, A. Ouzzane, 2011, Urology.

Adjuvant radiotherapy versus early salvage radiotherapy plus short-term androgen deprivation therapy in men with localised prostate cancer after radical prostatectomy (GETUG-AFU 17): a randomised, phase 3 trial.

N. Magné, D. Pasquier, S. Chabaud, 2020, The Lancet. Oncology.

[CCAFU Recommendations 2013: Prostate cancer].

L. Salomon, A. Villers, M. Peyromaure, 2013, Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie.

Prostate cancer surgical margin. CCAFU review

L. Salomon, M. Peyromaure, C. Hennequin, 2014 .

[Prostate cancer surgical margin: review by the CCAFU (Oncology Committee of the French Association of Urology)].

L. Salomon, M. Peyromaure, C. Hennequin, 2014, Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie.

Methodological considerations in cost of prostate cancer studies: a systematic review.

C. Combescure, J. Daurès, L. Molinier, 2008, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

The Tension–Free Transvaginal Tape Procedure in the Treatment of Female Urinary Stress Incontinence: A French Prospective Multicentre Study

P. Plante, M. Soulié, P. Seguin, 2001, European Urology.

[Survival analysis of adjustable continence therapy device (ACT®/proACT®): a new message for patients].

X. Gamé, É. Huyghe, M. Soulié, 2020, Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie.

[Treatment of bladder outlet obstruction secondary to suburethral tape by section of the tape].

X. Gamé, B. Malavaud, P. Plante, 2006, Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie.

[Efficacy and safety of Pelvicol in the vaginal treatment of prolapse].

N. Doumerc, É. Huyghe, P. Plante, 2006, Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie.

The effect of gender and age on kidney cancer survival: younger age is an independent prognostic factor in women with renal cell carcinoma.

J. Patard, A. Belldegrun, A. Pantuck, 2014, Urologic oncology.

Unclassified renal cell carcinoma: an analysis of 85 cases

F. Guillé, J. Patard, J. Lam, 2007, BJU international.

Androgen-deprivation therapy alone or with docetaxel in non-castrate metastatic prostate cancer (GETUG-AFU 15): a randomised, open-label, phase 3 trial.

A. Ravaud, J. Machiels, B. Esterni, 2013, The Lancet. Oncology.

Patients' self-assessment of tolerance and quality of life during docetaxel-based chemotherapy: Results from a phase III trial in hormone-naive metastatic prostate cancer patients (GETUG-AFU 15/0403).

B. Esterni, S. Oudard, G. Gravis, 2010 .

[French ccAFU guidelines - Update 2018-2020: Prostate cancer].

A. Ouzzane, G. Cancel-Tassin, O. Cussenot, 2018, Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie.

Scrotal location of Madelung's disease

M. Costagliola, M. Soulié, J. Grolleau, 1997, European Journal of Plastic Surgery.

Highlights on Prostate Cancer from Urological and Oncological Congresses in 2007.

L. Salomon, J. Schalken, A. Heidenreich, 2008 .

[French ccAFU guidelines - Update 2018-2020: Prostate cancer].

A. Ouzzane, G. Cancel-Tassin, O. Cussenot, 2018, Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie.

External validation of a nomogram for identification of pathologically favorable disease in intermediate risk prostate cancer patients

A. Ouzzane, G. Gandaglia, A. Briganti, 2017, The Prostate.

Estetrol, a Fetal Selective Estrogen Receptor Modulator, Acts on the Vagina of Mice through Nuclear Estrogen Receptor α Activation.

J. Foidart, F. Lenfant, X. Gamé, 2017, The American journal of pathology.

Evaluation of the impact of a clinical pathway on the progression of acute urinary retention

X. Gamé, J. Gas, É. Huyghe, 2018, Neurourology and urodynamics.

Multi-institutional study of complications in 1085 laparoscopic urologic procedures.

A. Hoznek, L. Salomon, P. Antiphon, 2001, Urology.

Urological complications of laparoscopic surgery: experience with 350 procedures at a single center.

P. Plante, M. Soulié, P. Seguin, 2001, The Journal of urology.

What is the Role of Surgery for Locally Advanced Disease

M. Soulié, M. Soulie, 2008 .

Clinicopathological characteristics of urothelial bladder cancer in patients less than 40 years old

O. Cussenot, G. Pignot, N. Houédé, 2015, Virchows Archiv.

[Surgery of prostate cancer: Technical principles and perioperative complications].

L. Salomon, F. Rozet, M. Soulié, 2015, Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie.

[Prostate brachytherapy: indications and outcomes].

L. Salomon, M. Peyromaure, C. Hennequin, 2013, Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie.

Quality of life associated with orthotopic neobladder and ileal conduit in women: A multicentric cross-sectional study.

B. Peyronnet, X. Gamé, J. Fantoni, 2020, Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie.

A multicenter study of the morbidity of radical cystectomy in select elderly patients with bladder cancer.

R. Hautmann, X. Gamé, P. Plante, 2002, The Journal of urology.

[Treatment of infiltrating nonmetastatic bladder cancers in elderly patients].

H. Wallerand, F. Saint, M. Rouprêt, 2009, Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie.

Living-donor kidney transplantation: comparison of sequential and simultaneous surgical organizations

X. Gamé, N. Doumerc, S. Mittal, 2020, International Urology and Nephrology.

Assessment of morbidity and functional results in bladder replacement with Hautmann ileal neobladder after radical cystectomy: a clinical experience in 55 highly selected patients.

M. Thoulouzan, P. Plante, M. Soulié, 2001, Urology.

[CCAFU french national guidelines 2016-2018 on prostate cancer].

A. Ouzzane, G. Cancel-Tassin, O. Cussenot, 2016, Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie.

[Postoperative radiotherapy of prostate cancer].

L. Salomon, P. François, A. García, 2014, Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique.

Experience with retroperitoneal laparoscopic adrenalectomy for pheochromocytoma.

A. Hoznek, L. Salomon, F. Saint, 2001, The Journal of urology.

Recommandations en Onco-Urologie 2010 : Cancer du rein

N. Rioux-Leclercq, J. Patard, H. Lang, 2010 .

The role of American Society of Anesthesiologists scores in predicting urothelial carcinoma of the upper urinary tract outcome after radical nephroureterectomy: results from a national multi‐institutional collaborative study

A. Ouzzane, P. Colin, G. Pignot, 2012, BJU international.

Clinicopathological features and prognosis of synchronous bilateral renal cell carcinoma: an international multicentre experience

J. Patard, J. Bernhard, J. Lam, 2007, BJU international.

Local recurrence after radical nephrectomy for kidney cancer: management and prediction of outcomes. a multi‐institutional study

K. Bensalah, J. Patard, L. Salomon, 2014, Journal of surgical oncology.

Micrometastatic adrenal invasion by renal carcinoma in patients undergoing nephrectomy.

P. Plante, M. Soulié, G. Escourrou, 1996, British journal of urology.

Extraperitoneal laparoscopic pyeloplasty: a multicenter study of 55 procedures.

J. Patard, C. Abbou, L. Salomon, 2001, The Journal of urology.

Renal angiomyolipoma associated with rapid enlargement [correction of enlargment] and inferior vena caval tumor thrombus.

X. Gamé, C. Chevreau, M. Soulié, 2003, The Journal of urology.

Laparoscopic nephrectomy for polycystic kidney: comparison of the transperitoneal and retroperitoneal approaches

K. Bensalah, D. Chauveau, B. Peyronnet, 2016, World Journal of Urology.

Second non-germ cell malignancies in patients treated for stage I-II testicular seminoma.

F. Berthier, N. Daly-Schveitzer, P. Grosclaude, 1999, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Deep Neural Networks Outperform the CAPRA Score in Predicting Biochemical Recurrence After Prostatectomy

G. Gandaglia, V. Vinh-Hung, F. Rozet, 2021, Frontiers in Oncology.

[Incidence and mortality of urological cancers in 2012 in France].

J. Patard, L. Salomon, A. Villers, 2013, Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie.

[Nephron-sparing surgery is superior to radical nephrectomy in preserving renal function outcome in tumors larger than 4 cm].

J. Patard, J. Bernhard, L. Salomon, 2011, Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie.

Improved decision making in intermediate-risk prostate cancer: a multicenter study on pathologic and oncologic outcomes after radical prostatectomy

L. Salomon, A. Ouzzane, A. De la taille, 2017, World Journal of Urology.

Clinical outcomes after salvage radiotherapy without androgen deprivation therapy in patients with persistently detectable PSA after radical prostatectomy: results from a national multicentre study

L. Salomon, F. Saint, A. Ouzzane, 2014, World Journal of Urology.

Comparison of the prognosis of primary vs. progressive muscle invasive bladder cancer after radical cystectomy: Results from a large multicenter study.

I. Ouzaid, B. Peyronnet, F. Nouhaud, 2020, Urologic oncology.

[French ccAFU guidelines - update 2020-2022: prostate cancer].

O. Cussenot, F. Bruyère, X. Rébillard, 2020, Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie.

Experience with retroperitoneal laparoscopic adrenalectomy in 115 procedures.

A. Hoznek, L. Salomon, F. Saint, 2001, The Journal of urology.

Retroperitoneal laparoscopic adrenalectomy: clinical experience in 52 procedures.

P. Caron, P. Plante, M. Soulié, 2000, Urology.

[Ureteral and vesicular endometriosis: case report].

X. Monroziès, O. Parant, M. Soulié, 1999, Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie.

[Primary carcinoid tumor and horseshoe kidney: potential association].

B. Suc, P. Plante, M. Soulié, 2001, Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie.

[Urothelial carcinoma in patients under 40 years. Review of the cancer committee of the French Association of Urology].

E. Compérat, P. Camparo, G. Pignot, 2013, Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie.

[The new uretero-ileal anastomosis technique in Hautmann ileal neobladder].

R. Hautmann, J. Gschwend, M. Soulié, 2001, Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie.

Pathologic findings in radical prostatectomy specimens from patients eligible for active surveillance with highly selective criteria: a multicenter study.

L. Salomon, J. Long, M. Rouprêt, 2012, Urology.

Migration in last decade to high-risk prostate cancer after radical prostatectomy.

L. Salomon, A. De la taille, X. Gamé, 2019, Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie.

[Prostate cancer screening].

A. Villers, X. Rébillard, J. Irani, 2003, Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie.

[Management of low-risk prostate cancer].

L. Salomon, M. Peyromaure, C. Hennequin, 2015, Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie.

Contents Vol. 39, 2001

Chien-Cheng Chang, C. Windischberger, E. Moser, 2001, European Urology.

Comparison of red blood cell volume distribution curves and phase-contrast microscopy in localization of the origin of hematuria.

X. Gamé, J. Corberand, P. Plante, 2003, Urology.

[Can urinary corpuscular volume using automated hematology contribute the diagnostic etiology of hematuric microscopy?].

X. Gamé, J. Corberand, P. Plante, 2002, Progrès en urologie (Paris).

[Does a tumor size higher than 7cm impact partial nephrectomy outcomes for the treatment of renal cancer?].

X. Gamé, N. Doumerc, F. Nouhaud, 2015, Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie.

Retroperitoneoscopic adrenalectomy: comparison of retrograde and antegrade approach among a series of 279 cases.

P. Caron, J. Amar, B. Chamontin, 2013, Urology.

Long-term oncological outcomes after robotic partial nephrectomy for renal cell carcinoma: a prospective multicentre study

K. Bensalah, B. Peyronnet, Z. Khene, 2018, World Journal of Urology.

Total intracorporeal robotic renal auto-transplantation: A new minimally invasive approach to preserve the kidney after major ureteral injuries

X. Gamé, N. Doumerc, M. Soulié, 2018, International journal of surgery case reports.

[Renal oncocytoma. Report of 13 cases].

J. Tostain, P. Plante, M. Soulié, 1997, Annales d'urologie.

Neoadjuvant targeted molecular therapies in patients undergoing nephrectomy and inferior vena cava thrombectomy: is it useful?

K. Bensalah, N. Rioux-Leclercq, J. Patard, 2014, World Journal of Urology.

[Retroperitoneal laparoscopic adrenalectomy: a safe and reproducible technique].

C. Abbou, L. Salomon, F. Saint, 2001, Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie.

[Retroperitoneoscopic pyeloplasty for primary hydronephrosis: preliminary results of the first 30 procedures].

P. Plante, M. Soulié, P. Seguin, 2001, Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie.

[Retroperitoneal laparoscopic surgery for phaeochromocytoma: analysis of morbidity and haemodynamic instability].

P. Caron, J. Amar, B. Chamontin, 2007, Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie.

Brachytherapy for penile cancer: efficacy and impact on sexual function.

O. Riou, B. Malavaud, É. Huyghe, 2014, Brachytherapy.

Positive surgical margin appears to have negligible impact on survival of renal cell carcinomas treated by nephron-sparing surgery.

K. Bensalah, N. Rioux-Leclercq, J. Patard, 2010, European urology.

[The place of laparoscopic nephrectomy in the elderly subject].

N. Rioux-Leclercq, J. Patard, H. Lang, 2009, Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie.

[CCAFU Recommendations 2013: Renal cancer].

K. Bensalah, N. Rioux-Leclercq, J. Patard, 2013, Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie.

[Laparoscopy-assisted vaginal pelvic exenteration].

N. Chopin, D. Querleu, G. Ferron, 2006, Gynecologie, obstetrique & fertilite.

[Prospective study of the results of ureterointestinal anastomosis in 100 patients after the Hautmann ileal neobladder with double chimney].

M. Thoulouzan, É. Huyghe, P. Plante, 2012, Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie.

Robotic Kidney Transplantation for Morbidly Obese Patients Excluded from Traditional Transplantation

N. Doumerc, N. Kamar, P. Rischmann, 2017, Obesity Surgery.

Predictive model of 1-year postoperative renal function after living donor nephrectomy

X. Gamé, N. Doumerc, N. Kamar, 2017, International Urology and Nephrology.

Intra-database validation of case-identifying algorithms using reconstituted electronic health records from healthcare claims data

F. Guillemin, C. Louapre, B. Brochet, 2021, BMC Medical Research Methodology.

Current impact of age and comorbidity assessment on prostate cancer treatment choice and over/undertreatment risk

P. Grosclaude, B. Malavaud, M. Soulié, 2017, World Journal of Urology.

Endoscopic enucleation for prostate larger than 60 mL: comparison between holmium laser enucleation and plasmakinetic enucleation

X. Gamé, B. Malavaud, É. Huyghe, 2020, World Journal of Urology.

Summary of the Standards, Options and Recommendations for the management of patients with nonmetastatic prostate cancer (2001)

A. Villers, B. Fervers, A. Bataillard, 2003, British Journal of Cancer.

Impact of Patient- and Clinician-Reported Cumulative Toxicity on Quality of Life in Patients With Metastatic Castration-Naïve Prostate Cancer.

J. Dekker, H. Verheul, S. Oudard, 2018, Journal of the National Comprehensive Cancer Network : JNCCN.

[Partial nephrectomy vs. radical nephrectomy for tumor>7cm].

N. Doumerc, F. Nouhaud, M. Soulié, 2015, Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie.

[Androgen suppression for the treatment of prostate cancer in the elderly].

L. Salomon, M. Peyromaure, V. Molinie, 2009, Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie.

Benign prostatic hyperplasia endoscopic surgical procedures in kidney transplant recipients: a comparison between HoLEP, GreenLight photoselective vaporization of the prostate and TURP.

G. Robert, X. Gamé, N. Kamar, 2019, Journal of endourology.

Benign Prostatic Hyperplasia Endoscopic Surgical Procedures in Kidney Transplant Recipients: A Comparison Between Holmium Laser Enucleation of the Prostate, GreenLight Photoselective Vaporization of the Prostate, and Transurethral Resection of the Prostate

G. Robert, X. Gamé, N. Kamar, 2019 .

Ejaculatory function after permanent 125I prostate brachytherapy for localized prostate cancer.

M. Thoulouzan, É. Huyghe, P. Plante, 2009, International journal of radiation oncology, biology, physics.

[Do ablative treatments modify the management of kidney tumors in the elderly?].

N. Rioux-Leclercq, J. Patard, H. Lang, 2009, Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie.

[Pathological stage T3 prostate cancer after radical prostatectomy: a retrospective study of 246 cases].

X. Gamé, B. Malavaud, P. Plante, 2008, Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie.

Patients' self-assessment versus investigators' evaluation in a phase III trial in non-castrate metastatic prostate cancer (GETUG-AFU 15).

A. Ravaud, J. Machiels, B. Esterni, 2014, European journal of cancer.

Proposal for a predictive model of erectile function after permanent 125I prostate brachytherapy for localized prostate cancer

J. Bachaud, É. Huyghe, M. Soulié, 2013, International Journal of Impotence Research.

Complete Transurethral Resection before Radical Cystectomy May Improve Oncological Outcomes

K. Bensalah, N. Rioux-Leclercq, F. Guillé, 2021, Urologia Internationalis.

[Fertility after prostate brachytherapy with Iode 125 permanent implants for localized prostate cancer].

J. Bachaud, M. Thoulouzan, É. Huyghe, 2012, Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie.

Is there a volume–outcome relationship for partial nephrectomy?

K. Bensalah, J. Patard, J. Bernhard, 2014, World Journal of Urology.

Androgen deprivation therapy (ADT) plus docetaxel (D) versus ADT alone for hormone-naïve metastatic prostate cancer (PCa): Long-term analysis of the GETUG-AFU 15 phase III trial.

G. Deplanque, S. Oudard, G. Gravis, 2015 .

[Epidemiology of emergency consultations for acute urine retention].

X. Gamé, J. Gas, É. Huyghe, 2018, Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie.

[Conclusion and perspectives].

L. Salomon, M. Soulié, 2015, Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie.

[CCAFU Recommendations 2013: Upper urinary tract carcinoma].

E. Compérat, P. Colin, G. Pignot, 2013, Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie.

Stage pT0 after radical prostatectomy with previous positive biopsy sets: a multicenter study.

L. Salomon, M. Peyromaure, V. Ravery, 2010, The Journal of urology.

[Checkup and management of upper urinary tract tumours in 2010: An update from the committee of cancer from the French National Association of Urology].

H. Wallerand, F. Saint, O. Traxer, 2010, Progrès en urologie (Paris).

Localized chromophobe carcinomas treated by nephron-sparing surgery have excellent oncologic outcomes.

K. Bensalah, J. Patard, J. Bernhard, 2017, Urologic oncology.

[Management of positive margins after total prostatectomy for localized prostate cancer].

J. Tostain, M. Soulié, M. de Fromont, 2006, Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie.

[Retroperitoneal sarcoma: contribution to the repository CCAFU INCA.].

S. Culine, P. Camparo, P. Sèbe, 2010, Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie.

Urinary/serum prostate-specific antigen ratio: comparison with free/total serum prostate-specific antigen ratio in improving prostate cancer detection.

L. Salomon, A. Zlotta, A. De la taille, 2005, Urology.

[CCAFU Recommendations 2013: Diagnosis, treatment, follow up of urological cancers].

J. Patard, L. Salomon, T. Lebret, 2013, Progrès en urologie (Paris).

[The screening of prostate cancer in 2009: overview of the oncology committee of the French Urological Association].

L. Salomon, A. Villers, M. Peyromaure, 2010, Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie.

[Salvage treatments following prostate radiation therapy: role of the urologist].

L. Salomon, M. Soulié, M. Soulie, 2014, Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique.

[Recommendations Onco-Urology 2010: Urothelial tumors].

H. Wallerand, F. Saint, N. Houédé, 2010, Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie.

[T1 bladder carcinoma: prognostic value of the muscularis mucosae invasion (T1a/T1b). A multicenter study by the French Urological Association (CCAFU)].

M. Rouprêt, O. Celhay, F. Rozet, 2010, Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie.

[Recommendations for best practice for prostate biopsy].

L. Salomon, A. Ouzzane, A. Villers, 2011, Progrès en urologie (Paris).

[Imagery of treated prostate cancer].

L. Salomon, M. Peyromaure, C. Hennequin, 2015, Progrès en urologie (Paris).

The prognostic value of high-grade prostate cancer pattern on MRI-targeted biopsies: predictors for downgrading and importance of concomitant systematic biopsies

C. Almeras, B. Malavaud, M. Soulié, 2021, World Journal of Urology.

Cost study of the clinical management of prostate cancer in France: results on the basis of population-based data

J. Daurès, L. Molinier, X. Rébillard, 2011, The European Journal of Health Economics.

[Orgasm after curietherapy with permanent iodine-125 radioimplants for localized prostate cancer].

J. Bachaud, M. Thoulouzan, É. Huyghe, 2011, Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie.

Randomized phase III trial of dose-dense methotrexate, vinblastine, doxorubicin, and cisplatin (dd-MVAC) or gemcitabine and cisplatin (GC) as perioperative chemotherapy for muscle invasive urothelial bladder cancer (MIUBC): Preliminary results of the GETUG/AFU V05 VESPER trial on toxicity and pathol

S. Culine, Y. Allory, G. Gravis, 2020 .

Medical and non-medical determinants of prostate cancer management: a population-based study.

A. Villers, J. Macé-Lesec’h, P. Grosclaude, 2003, European journal of cancer.

[Cancer of the prostate in France: results of the survey CCAFU-FRANCIM].

A. Villers, L. Molinier, J. Macé-Lesec’h, 2001, Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie.

Transrectal high-intensity focused ultrasound in the treatment of localized prostate cancer.

Michel Soulie, Guy Vallancien, Xavier Rebillard, 2005, Journal of endourology.

A modified intussuscepted nipple in the Kock pouch urinary diversion: assessment of perioperative complications and functional results

P. Plante, M. Soulié, P. Seguin, 2002, BJU international.

[Treatment by HIFU of prostate cancer: survey of literature and treatment indications].

X. Rébillard, M. Soulié, J. Davin, 2003, Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie.

[A prospective trial comparing consecutive series of open retropubic and robot-assisted laparoscopic radical prostatectomy in a centre: Oncologic and functional outcomes].

N. Doumerc, B. Malavaud, P. Rischmann, 2015, Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie.